Article
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
International journal of colorectal disease - 1 Aug 2020
Roberto Michela, Marchetti Paolo, Arrivi Giulia, Di Pietro Francesca Romana, Cascinu Stefano, Gelsomino Fabio, Caputo Francesco, Cerma Krisida, Ghidini Michele, Ratti Margherita, Pizzo Claudio, Ficorella Corrado, Parisi Alessandro, Cortellini Alessio, Urbano Federica, Calandrella Maria Letizia, Botticelli Andrea, Dell'Aquila Emanuela, Minelli Alessandro, Fulgenzi Claudia, Montori Andrea, Pilozzi Emanuela, Mazzuca Federica
Abstract excerpt
PURPOSE: BRAF mutations represent the main negative prognostic factor for metastatic colorectal cancer and a supposed negative predictive factor of response to standard chemotherapy. We have explored survival difference in right-sided colon cancer (RCC) patients according to BRAF mutations, with the aim to identify any predictive factors of response to targeted-based therapy. METHODS: A retrospective study of RCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
